{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:38:13Z","timestamp":1789749493533,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T00:00:00Z","timestamp":1372982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10620-013-2762-2","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T04:10:37Z","timestamp":1372911037000},"page":"2949-2954","source":"Crossref","is-referenced-by-count":73,"title":["Characteristics and Treatment of Pyoderma Gangrenosum in Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"58","author":[{"given":"F.","family":"Arg\u00fcelles-Arias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Castro-Laria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lobat\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aguas-Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rojas-Feria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Barreiro-de Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Soto-Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Calvo-Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ginard-Vicens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chaparro-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hern\u00e1ndez-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Castro-Senosiain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fern\u00e1ndez-Villaverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Garc\u00eda-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dom\u00ednguez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Caunedo-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Herrer\u00edas-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"key":"2762_CR1","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","volume":"23","author":"E Ruocco","year":"2009","unstructured":"Ruocco E, Sangiuliano S, Gravina AG, Miranda A, et al. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol. 2009;23:1008\u20131017.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2762_CR2","doi-asserted-by":"crossref","unstructured":"Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am 2007;33:787\u2013802.","DOI":"10.1016\/j.rdc.2007.07.016"},{"key":"2762_CR3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1155\/2005\/323914","volume":"19","author":"HJ Freeman","year":"2005","unstructured":"Freeman HJ. Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn\u2019s disease. Can J Gastroenterol. 2005;19:603\u2013606.","journal-title":"Can J Gastroenterol"},{"key":"2762_CR4","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","volume":"96","author":"CN Bernstein","year":"2001","unstructured":"Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116\u20131122.","journal-title":"Am J Gastroenterol"},{"key":"2762_CR5","first-page":"88","volume":"6","author":"Y Menachem","year":"2004","unstructured":"Menachem Y, Gotsman I. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease. Isr Med Assoc J. 2004;6:88\u201390.","journal-title":"Isr Med Assoc J"},{"key":"2762_CR6","first-page":"235","volume":"7","author":"JS Levine","year":"2011","unstructured":"Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2011;7:235\u2013241.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"2762_CR7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(97)10187-8","volume":"351","author":"JP Callen","year":"1998","unstructured":"Callen JP. Pyoderma gangrenosum. Lancet. 1998;351:581\u2013585.","journal-title":"Lancet"},{"key":"2762_CR8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/bmj.333.7560.181","volume":"333","author":"T Brooklyn","year":"2006","unstructured":"Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. BMJ. 2006;333:181\u2013184.","journal-title":"BMJ"},{"key":"2762_CR9","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/archderm.1992.01680180054005","volume":"128","author":"WL Matis","year":"1992","unstructured":"Matis WL, Ellis CN, Griffiths CE, Lazarus GS. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol. 1992;128:1060\u20131064.","journal-title":"Arch Dermatol"},{"key":"2762_CR10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","volume":"55","author":"TN Brooklyn","year":"2006","unstructured":"Brooklyn TN, Dunnill MGS, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut. 2006;55:505\u2013509.","journal-title":"Gut"},{"key":"2762_CR11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archderm.143.3.306","volume":"143","author":"MP Heffernan","year":"2007","unstructured":"Heffernan MP, Anadkat MJ, Smith DI. Adalimumab treatment for pyoderma gangrenosum. Arch Dermatol. 2007;143:306\u2013308.","journal-title":"Arch Dermatol"},{"key":"2762_CR12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.crohns.2012.07.021","volume":"7","author":"G Andrisani","year":"2013","unstructured":"Andrisani G, Guidi L, Papa A, et al. A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery. J Crohns Colitis. 2013;7:421\u2013426.","journal-title":"J Crohns Colitis"},{"key":"2762_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","volume":"4","author":"G Assche Van","year":"2010","unstructured":"Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease: special situations. J Crohns Colitis. 2010;4:63\u2013101.","journal-title":"J Crohns Colitis"},{"key":"2762_CR14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study. Gastroenterology. 1976;70:439\u2013444.","journal-title":"Gastroenterology"},{"key":"2762_CR15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","volume":"2","author":"SC Truelove","year":"1955","unstructured":"Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041\u20131048.","journal-title":"Br Med J"},{"key":"2762_CR16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","volume":"53","author":"J Reichrath","year":"2005","unstructured":"Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol. 2005;53:273\u2013283.","journal-title":"J Am Acad Dermatol"},{"key":"2762_CR17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jaad.2009.05.030","volume":"62","author":"J Miller","year":"2010","unstructured":"Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR. Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol. 2010;62:646\u2013654.","journal-title":"J Am Acad Dermatol"},{"key":"2762_CR18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jamcollsurg.2007.07.023","volume":"206","author":"LS Poritz","year":"2008","unstructured":"Poritz LS, Lebo MA, Bobb AD, et al. Management of peristomal pyoderma gangrenosum. J Am Coll Surg. 2008;206:311\u2013315.","journal-title":"J Am Coll Surg"},{"key":"2762_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00054725-200102000-00001","volume":"7","author":"S Friedman","year":"2001","unstructured":"Friedman S, Marion JF, Scherl E, Rubin PH, Present DH. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Inflamm Bowel Dis. 2001;7:1\u20137.","journal-title":"Inflamm Bowel Dis"},{"key":"2762_CR20","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/j.1572-0241.2003.07581.x","volume":"98","author":"M Regueiro","year":"2003","unstructured":"Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol. 2003;98:1821\u20131826.","journal-title":"Am J Gastroenterol"},{"key":"2762_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ibd.21663","volume":"18","author":"R L\u00f6fberg","year":"2012","unstructured":"L\u00f6fberg R, Louis EV, Reinisch W, Robinson AM, et al. Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn\u2019s disease: results from CARE. Inflamm Bowel Dis. 2012;18:1\u20139.","journal-title":"Inflamm Bowel Dis"},{"key":"2762_CR22","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3748\/wjg.15.2293","volume":"15","author":"E Zold","year":"2009","unstructured":"Zold E, Nagy A, Devenyi K, Zeher M, Barta Z. Successful use of adalimumab for treating fistulizing Crohn\u2019s disease with pyoderma gangrenosum: two birds with one stone. World J Gastroenterol. 2009;15:2293\u20132295.","journal-title":"World J Gastroenterol"},{"key":"2762_CR23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","volume":"146","author":"WJ Sandborn","year":"2007","unstructured":"Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. Ann Intern Med. 2007;146:829\u2013838.","journal-title":"Ann Intern Med"},{"key":"2762_CR24","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","volume":"353","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462\u20132476.","journal-title":"N Engl J Med"},{"key":"2762_CR25","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/gut.2010.221127","volume":"60","author":"W Reinisch","year":"2011","unstructured":"Reinisch W, Sandborn WJ, Hommes DW, D\u2019Haens G, et al. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Gut. 2011;60:780\u2013787.","journal-title":"Gut"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-013-2762-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-013-2762-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-013-2762-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T23:13:05Z","timestamp":1563318785000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-013-2762-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,5]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["2762"],"URL":"https:\/\/doi.org\/10.1007\/s10620-013-2762-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,5]]}}}